KasaConsult bvba   Report issue

For profit Phase 3
Founded: Hoegaarden Belgium (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2008
NCT00630812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Europe: KasaConsult bvba, Hoegaarden, Belgium

Active Ingredients

Drugs in Phase 3 Trials (1)

mannitol (Osmitrol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 3)

Fibrosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1